OMAHA, Neb. (April 27, 2017)—Catherine Murari-Kanti, Ph.D., has been promoted from intern to a full-time licensing associate position with UNeMed, the technology transfer and commercialization office at the University of Nebraska Medical Center.
“Dr. Murari-Kanti is one of those rare people who had a clear trajectory right from the beginning,” UNeMed president and CEO Michael Dixon said. “She’s been on our radar basically since she first arrived on campus about five years ago. It’s great to have someone like her who can hit the ground running like she has.”
The promotion and full-time status expands her role of evaluating, marketing, and seeking partnerships for new inventions, cures, treatments and medical devices developed at UNMC.
UNeMed’s mission is to help UNMC researchers, faculty and staff move innovations and ground-breaking discoveries beyond the laboratory and into the marketplace. Dr. Murari-Kanti joins UNeMed’s talented stable of licensing experts who work every day to advance UNMC’s new discoveries into the future cures and treatments that might one-day affect millions around the world.
“I’m excited as a graduate of UNMC to have the ability to share exciting discoveries made here, with the world,” Dr. Murari-Kanti said. “I’m proud that my career started with UNeMed and look forward to learn and grow in technology transfer and better serve the UNMC and Omaha community.”
A native of Mumbai, India, Dr. Murari is the daughter of Krishnamurty and Vijayakumari Murari. She is a 2009 graduate of Creighton University in Pharmaceutical Sciences with an undergraduate degree in Pharmaceutical Sciences from the University of Mumbai. Dr. Murari-Kanti received her doctorate in Cancer Research from UNMC in 2015.